COVID-19 Vaccine: Sputnik V Finally Gets DCGI Nod For Phase 2/3 Trials In India
New Delhi: Having refused permission earlier, the Drugs Controller General of India (DCGI) has now allowed Dr Reddy’s to conduct phase 2/3 clinical human trials of Russia’s Sputnik V vaccine candidate.
“This will be a multi-centre and…